Tema Oncology ETF (CANC): ETF
ETF traded on XNAS under symbol CANC. Quoted in usd.
Tema Oncology ETF
+2.62%$41.85
XNAS:CANCEquity
AUM $213.95M·YTD --·Yield --
XNAS:CANC$41.85+2.62%AUM $213.95MAbout CANC
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
Largest holdings
- GMAB GENMAB A/S5.94%
- RVMD REVOLUTION MEDICINES INC5.83%
- LLY ELI LILLY & CO5.16%
- MRK MERCK & CO INC4.89%
- COGT COGENT BIOSCIENCES INC4.67%
- NOVN.SW NOVARTIS AG4.17%
- ONC BEONE MEDICINES LTD4.15%
- ABBV ABBVIE INC3.75%
- EXEL EXELIXIS INC3.69%
- RHHBY ROCHE HOLDING AG3.10%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$106,707
Total Return
+$36,707
(+52.4%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$213.95M
NAV$41.87
Premium/Discount-0.05%
Expense Ratio0.99%
Market Cap--
Shares Outstanding--
Inception DateAug. 14, 2023
Fund Details
52-Week Range
$30.14$47.00
Current: $41.85
Volume
Volume56.69K
Avg Volume25.97K
Vol/Avg2.18x
30d
17.98K
60d
26.03K
90d
24.82K
Comparable ETFs